Literature DB >> 26773038

N-linked glycan stabilization of the VWF A2 domain.

Christopher J Lynch1, David A Lane1.   

Abstract

Shear forces in the blood trigger a conformational transition in the von Willebrand factor (VWF) A2 domain, from its native folded to an unfolded state, in which the cryptic scissile bond (Y1605-M1606) is exposed and can then be proteolysed by ADAMTS13. The conformational transition depends upon a Ca(2+)binding site and a vicinal cysteine disulfide bond. Glycosylation at N1574 has previously been suggested to modulate VWF A2 domain interaction with ADAMTS13 through steric hindrance by the bulky carbohydrate structure. We investigated how the N-linked glycans of the VWF A2 domain affect thermostability and regulate both the exposure of the ADAMTS13 binding sites and the scissile bond. We show by differential scanning fluorimetry that the N-linked glycans thermodynamically stabilize the VWF A2 domain. The essential component of the glycan structure is the first sugar residue (GlcNAc) at the N1574 attachment site. From its crystal structures, N1574-GlcNAc is predicted to form stabilizing intradomain interactions with Y1544 and nearby residues. Substitution of the surface-exposed Y1544 to aspartic acid is able to stabilize the domain in the absence of glycosylation and protect against ADAMTS13 proteolysis in both the VWF A2 domain and FLVWF. Glycan stabilization of the VWF A2 domain acts together with the Ca(2+)binding site and vicinal cysteine disulfide bond to control unfolding and ADAMTS13 proteolysis.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773038      PMCID: PMC4817312          DOI: 10.1182/blood-2015-09-672014

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  A mechanically stabilized receptor-ligand flex-bond important in the vasculature.

Authors:  Jongseong Kim; Cheng-Zhong Zhang; Xiaohui Zhang; Timothy A Springer
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

2.  A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13.

Authors:  Minyun Zhou; Xianchi Dong; Carsten Baldauf; Hua Chen; Yanfeng Zhou; Timothy A Springer; Xinping Luo; Chen Zhong; Frauke Gräter; Jianping Ding
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

3.  The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function.

Authors:  Brenda M Luken; Luke Y N Winn; Jonas Emsley; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

Review 4.  Biology and physics of von Willebrand factor concatamers.

Authors:  T A Springer
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

5.  Sequence and structure relationships within von Willebrand factor.

Authors:  Yan-Feng Zhou; Edward T Eng; Jieqing Zhu; Chafen Lu; Thomas Walz; Timothy A Springer
Journal:  Blood       Date:  2012-04-06       Impact factor: 22.113

6.  Calcium stabilizes the von Willebrand factor A2 domain by promoting refolding.

Authors:  Amy J Xu; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-22       Impact factor: 11.205

7.  Multi-step binding of ADAMTS-13 to von Willebrand factor.

Authors:  H B Feys; P J Anderson; K Vanhoorelbeke; E M Majerus; J E Sadler
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

8.  Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.

Authors:  Eric G Huizinga; Shizuko Tsuji; Roland A P Romijn; Marion E Schiphorst; Philip G de Groot; Jan J Sixma; Piet Gros
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

Review 9.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

10.  Calcium modulates force sensing by the von Willebrand factor A2 domain.

Authors:  Arjen J Jakobi; Alireza Mashaghi; Sander J Tans; Eric G Huizinga
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

View more
  15 in total

1.  Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.

Authors:  Alexander Tischer; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Matthew Auton
Journal:  J Thromb Haemost       Date:  2019-09-03       Impact factor: 5.824

2.  An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.

Authors:  Ebtesam A Gashash; Arya Aloor; Dong Li; He Zhu; Xiao-Qian Xu; Cong Xiao; Junping Zhang; Aishwarya Parameswaran; Jing Song; Cheng Ma; Weidong Xiao; Peng George Wang
Journal:  J Proteome Res       Date:  2017-07-27       Impact factor: 4.466

3.  Delimiting the autoinhibitory module of von Willebrand factor.

Authors:  W Deng; K M Voos; J K Colucci; E R Legan; E A Ortlund; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2018-08-16       Impact factor: 5.824

4.  Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.

Authors:  Alexander Tischer; Maria A Brehm; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Katelynn J Nelton; Rachel R Leger; Tobias Obser; Marina Martinez-Vargas; Steven T Whitten; Dong Chen; Rajiv K Pruthi; H Robert Bergen; Miguel A Cruz; Reinhard Schneppenheim; Matthew Auton
Journal:  J Mol Biol       Date:  2019-10-17       Impact factor: 5.469

5.  Stereoelectronic effects in stabilizing protein-N-glycan interactions revealed by experiment and machine learning.

Authors:  Maziar S Ardejani; Louis Noodleman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Chem       Date:  2021-03-15       Impact factor: 24.427

6.  Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.

Authors:  Kayleigh M Voos; Wenpeng Cao; Nicholas A Arce; Emily R Legan; Yingchun Wang; Asif Shajahan; Parastoo Azadi; Pete Lollar; Xiaohui Frank Zhang; Renhao Li
Journal:  J Thromb Haemost       Date:  2021-09-26       Impact factor: 16.036

7.  A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Authors:  Christopher J Lynch; Adam D Cawte; Carolyn M Millar; David Rueda; David A Lane
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

8.  Autoregulation of von Willebrand factor function by a disulfide bond switch.

Authors:  Diego Butera; Freda Passam; Lining Ju; Kristina M Cook; Heng Woon; Camilo Aponte-Santamaría; Elizabeth Gardiner; Amanda K Davis; Deirdre A Murphy; Agnieszka Bronowska; Brenda M Luken; Carsten Baldauf; Shaun Jackson; Robert Andrews; Frauke Gräter; Philip J Hogg
Journal:  Sci Adv       Date:  2018-02-28       Impact factor: 14.136

9.  A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.

Authors:  Kieron South; Marta O Freitas; David A Lane
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

Review 10.  The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.

Authors:  Soracha E Ward; Jamie M O'Sullivan; James S O'Donnell
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.